Immediate Transvaginal Ultrasound is the First-Line Diagnostic Test
This 53-year-old woman with 4 years of postmenopausal amenorrhea presenting with uterine bleeding requires urgent evaluation with transvaginal ultrasound (TVUS) as the initial diagnostic test, followed by endometrial tissue sampling if the endometrial thickness is ≥5 mm 1, 2.
Why This Matters
Postmenopausal bleeding carries approximately a 10% risk of endometrial cancer 3. While most cases have benign causes (atrophic endometrium, polyps, hyperplasia), the primary goal is to exclude malignancy. Even a single episode of bleeding after 4 years of menopause warrants full evaluation 2, 3.
Diagnostic Algorithm
Step 1: Transvaginal Ultrasound (First-Line)
- TVUS combined with transabdominal approach provides the initial assessment 1
- Measure endometrial thickness at the thickest point in longitudinal section
- Assess endometrial echogenicity and texture (abnormal patterns correlate with pathology even when thickness is normal) 1
- Evaluate for structural abnormalities: polyps, fibroids, adenomyosis
Step 2: Interpretation and Next Steps Based on Endometrial Thickness
If endometrial thickness <5 mm (specifically ≤4 mm):
- Negative predictive value for cancer approaches 100% 1, 2, 4
- Expectant management is appropriate 2, 5
- Follow-up in 3 months with repeat TVUS 5
- If bleeding recurs, proceed to tissue sampling regardless of thickness
If endometrial thickness ≥5 mm:
- Endometrial tissue sampling is mandatory 1, 6
- TVUS cannot reliably determine the etiology of thickening 1
- The threshold of ≥5 mm in postmenopausal women triggers biopsy 1
If endometrium is not measurable or visualization is incomplete:
- Proceed directly to tissue sampling 5
- Consider sonohysterography to better characterize focal abnormalities 1
Step 3: Tissue Sampling Method Selection
For diffuse endometrial thickening:
- Blind endometrial biopsy (office-based) is acceptable 4
For focal abnormalities (polyps, focal thickening on TVUS/sonohysterography):
- Hysteroscopy with visually directed biopsy is superior to blind sampling 6
- Provides higher diagnostic accuracy for detecting endometrial cancer, hyperplasia, and polyps 6
- Allows targeted removal of focal lesions
Critical Pitfalls to Avoid
Do not dismiss a single episode of bleeding: Even one day of bleeding after 4 years of menopause requires full evaluation 2, 3
Do not rely solely on endometrial thickness: Abnormal echogenicity or texture may indicate pathology even with normal thickness 1
Do not perform blind curettage alone: If tissue sampling is needed and focal abnormalities are present, hysteroscopy should be performed 5, 6
Do not delay evaluation: All postmenopausal bleeding should be referred urgently 3
If initial biopsy is non-diagnostic or inadequate tissue is obtained: Proceed to hysteroscopy rather than repeating blind sampling 5
Additional Considerations
Sonohysterography can be added after initial TVUS if focal endometrial abnormalities are detected, helping determine whether hysteroscopic versus blind biopsy is more appropriate 1
MRI is reserved for cases where ultrasound is inconclusive or the uterus cannot be completely visualized (large fibroids, adenomyosis obscuring endometrium) 1
Risk factors for endometrial cancer (obesity, diabetes, unopposed estrogen, tamoxifen use, Lynch syndrome) should be documented but do not change the evaluation algorithm—all postmenopausal bleeding requires investigation 2, 3
Summary of Immediate Actions
- Order transvaginal ultrasound urgently
- If ET ≥5 mm → endometrial sampling (hysteroscopy preferred if focal lesions present)
- If ET <5 mm → expectant management with 3-month follow-up
- If bleeding recurs or ET increases → proceed to tissue sampling